Iezza M.; Cortesi S.; Ottaviani E.; Mancini M.; Venturi C.; Monaldi C.; De Santis S.; Testoni N.; Soverini S.; Rosti G.; Cavo M.; Castagnetti F., Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights, «CELLS», 2023, 12, Article number: 1703, pp. 1703 - 1727 [articolo]Open Access
Mancini M.; Monaldi C.; De Santis S.; Papayannidis C.; Rondoni M.; Sartor C.; Bruno S.; Pagano L.; Criscuolo M.; Zanotti R.; Bonifacio M.; Tosi P.; Arock M.; Valent P.; Cavo M.; Soverini S., SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted, «BIOMARKER RESEARCH», 2023, 11, Article number: 29, pp. 29 - 41 [articolo]Open Access
de Santis S.; Monaldi C.; Martelli M.; Mancini M.; Bruno S.; Castagnetti F.; Gugliotta G.; Polakova K.M.; Ernst T.; Maar D.; Corner A.; Cavo M.; Soverini S., CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2022, 22, pp. 289 - 290 [articolo]
Mancini M.; Monaldi C.; De Santis S.; Rondoni M.; Papayannidis C.; Sartor C.; Curti A.; Bruno S.; Cavo M.; Soverini S., Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells, «CANCERS», 2022, 14, pp. 738 - 750 [articolo]Open Access
Soverini S.; De Santis S.; Martelli M.; Monaldi C.; Castagnetti F.; Gugliotta G.; Papayannidis C.; Mancini M.; Bruno S.; Venturi C.; Machova Polakova K.; Ernst T.; Maar D.; Corner A.; Cavo M., Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia, «LEUKEMIA», 2022, 36, pp. 2250 - 2260 [articolo]
Monaldi C.; de Santis S.; Mancini M.; Papayannidis C.; Sartor C.; Rondoni M.; Bruno S.; Cavo M.; Soverini S., MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2022, 22, pp. S328 - S328 [articolo]
De Santis S.; Monaldi C.; Mancini M.; Bruno S.; Cavo M.; Soverini S., Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia, «ONCOTARGETS AND THERAPY», 2022, 15, pp. 103 - 116 [articolo]Open Access
Mancini M.; De Santis S.; Monaldi C.; Castagnetti F.; Lonetti A.; Bruno S.; Dan E.; Sinigaglia B.; Rosti G.; Cavo M.; Gugliotta G.; Soverini S., Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors, «FRONTIERS IN ONCOLOGY», 2022, 12, Article number: 901132, pp. 1 - 13 [articolo]Open Access
Bruno S.; Bandini L.; Patuelli A.; Robustelli V.; Venturi C.; Mancini M.; Forte D.; De Santis S.; Monaldi C.; Grassi A.; Chiurumbolo G.; Paolini S.; Cristiano G.; Papayannidis C.; Sartor C.; Nanni J.; Ottaviani E.; Curti A.; Cavo M.; Soverini S., Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia, «FRONTIERS IN ONCOLOGY», 2021, 11, Article number: 728613, pp. 728613 - 728619 [articolo]Open Access
Monaldi C.; de Santis S.; Mancini M.; Bruno S.; Cavo M.; Soverini S., Systemic mastocytosis: Molecular landscape and implications for treatment, «MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES», 2021, 13, pp. e2021046 - e2021046 [articolo]Open Access
Soverini S.; De Santis S.; Monaldi C.; Bruno S.; Mancini M., Targeting leukemic stem cells in chronic myeloid leukemia: Is it worth the effort?, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, pp. 7093 - 7115 [articolo]Open Access
Bruno S.; Mancini M.; De Santis S.; Monaldi C.; Cavo M.; Soverini S., The role of hypoxic bone marrow microenvironment in acute myeloid leukemia and future therapeutic opportunities, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, Article number: 6857, pp. 1 - 18 [articolo]Open Access
Mancini, Manuela; De Santis, Sara; Monaldi, Cecilia; Bavaro, Luana; Martelli, Margherita; Gugliotta, Gabriele; Castagnetti, Fausto; Rosti, Gianantonio; Santucci, Maria Alessandra; Martinelli, Giovanni; Cavo, Michele; Soverini, Simona, Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis, «HEMATOLOGICAL ONCOLOGY», 2020, 38, pp. 201 - 203 [articolo]
Martelli M.; Monaldi C.; De Santis S.; Bruno S.; Mancini M.; Cavo M.; Soverini S., Recent advances in the molecular biology of systemic mastocytosis: Implications for diagnosis, prognosis, and therapy, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2020, 21, Article number: 3987, pp. 3987 - 4007 [articolo]Open Access
Mancini M.; De Santis S.; Monaldi C.; Bavaro L.; Martelli M.; Castagnetti F.; Gugliotta G.; Rosti G.; Santucci M.A.; Martinelli G.; Cavo M.; Soverini S., Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2019, 38, Article number: 216, pp. 1 - 11 [articolo]Open Access
